GENE LOGIC INC. Announces Senior Appointments in Bioinformatics.COLUMBIA, Md.--(BW HealthWire)--March 24, 1997--GENE LOGIC INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . today announced the appointments of Shahid Shahid or Shaheed is a male given name common among Muslims. It is the Arabic word for witness or martyr. People with this name Famous people with this name include: See also
PI scientist - a person with advanced knowledge of one or more sciences and Systems Analyst at Science and Technology Corporation, a major Department of Defense contractor Noun 1. defense contractor - a contractor concerned with the development and manufacture of systems of defense armed forces, armed services, military, military machine, war machine - the military forces of a nation; "their military is the largest in the region"; based in New Mexico New Mexico, state in the SW United States. At its northwestern corner are the so-called Four Corners, where Colorado, New Mexico, Arizona, and Utah meet at right angles; New Mexico is also bordered by Oklahoma (NE), Texas (E, S), and Mexico (S). . During his tenure at Bayer, Mr. Imran was responsible for the design of the company's worldwide bioinformatics infrastructure, including development of software for access to gene sequence and expression data and alignment and mapping information. From August 1995 to November 1996, he was Group Leader - Systems in the Department of Bioinformatics at Merck & Co., Inc., Rahway, NJ and, from 1993 to 1995, Director of the Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller Computing Laboratory at the Waksman Institute, Rutgers University. In 1987, Mr. Imran received a B.A. degree in Computer Science and Mathematics from Rutgers University. He is an adjunct member of Rutgers University faculty. From 1990 to 1996, Mr. Bullard was responsible for the Directed Energy Database System, a multinational classified project. Previously he was a Senior Programmer at OptiMetrics, Inc., where he developed image analysis software. Mr. Bullard holds advanced qualifications in mathematics and computer science from New Mexico State University New Mexico State University, at Las Cruces; land-grant and state supported; coeducational; chartered and opened 1889 as a college. It became New Mexico State Univ. of Engineering, Agriculture, and Science in 1958 and adopted its present name in 1960. . GENE LOGIC INC, a privately-held company based in Columbia, Maryland, uses a proprietary system based on genomic technologies and bioinformatics to accelerate the discovery of novel drug targets. Such targets are critical to the development of innovative therapeutic products for major common diseases such as cancer, Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , osteoporosis and heart failure. Using its Accelerated Target Discovery platform, GENE LOGIC produces a complete, quantitative picture of all the genes used in a human cell ("Molecular Topography(TM)"). By creating a "molecular movie", a series of Molecular Topographies(TM), GENE LOGIC can monitor changes in gene expression patterns as a disease develops and progresses. These changes in gene expression are analyzed using GENE LOGIC'S GENE EXPRESS(TM) bioinformatics system to discover and prioritize potential drug targets. GENE LOGIC intends to license the drug targets and drug lead compounds to pharmaceutical company partners for clinical development and commercialization. To date, GENE LOGIC has raised $10 million from private investors, including Oxford Bioscience Partners and Hambro Health International. CONTACT: GENE LOGIC INC. Mark D. Gessler, 410/309-3100 ext. 109 mgessler@genelogic.com or Burns McClellan, Inc. James W. Heins, 212/505-1919 jheins@burnsmc.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion